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Abstract
Background: Hand dermatitis can be a serious health problem in healthcare workers. While a range of skin care
strategies and policy directives have been developed in recent years to minimise the risk, their effectiveness and
cost-effectiveness remain unclear. Evidence now suggests that psychological theory can facilitate behaviour change
with respect to improved hand care practices. Therefore, we will test the hypothesis that a behavioural change
intervention to improve hand care, based on the Theory of Planned Behaviour and implementation intentions,
coupled with provision of hand moisturisers, can produce a clinically useful reduction in the occurrence of hand
dermatitis, when compared to standard care, among nurses working in the UK National Health Service (NHS) who
are particularly at risk. Secondary aims will be to assess impacts on participants’ beliefs and behaviour regarding
hand care. In addition, we will assess the cost-effectiveness of the intervention in comparison with normal care.
Methods/Design: We will conduct a cluster randomised controlled trial at 35 NHS hospital trusts/health boards/
universities, focussing on student nurses with a previous history of atopic disease or hand eczema and on nurses
in intensive care units.
Nurses at ‘intervention-light’ sites will be managed according to what would currently be regarded as best practice, with
provision of an advice leaflet about optimal hand care to prevent hand dermatitis and encouragement to contact their
occupational health (OH) department early if hand dermatitis occurs. Nurses at ‘intervention-plus’ sites will additionally
receive a behavioural change programme (BCP) with on-going active reinforcement of its messages, and enhanced
provision of moisturising cream.
The impact of the interventions will be compared using information collected by questionnaires and through
standardised photographs of the hands and wrists, collected at baseline and after 12 months follow-up. In addition,
we will assemble relevant economic data for an analysis of costs and benefits, and collect information from various
sources to evaluate processes.
Statistical analysis will be by multi-level regression modelling to allow for clustering by site, and will compare the
prevalence of outcome measures at follow-up after adjustment for values at baseline. The principal outcome measure
will be the prevalence of visible hand dermatitis as assessed by the study dermatologists. In addition, several secondary
(Continued on next page)
* Correspondence: ira.madan@kcl.ac.uk
1Guy’s and St Thomas’ NHS Foundation Trust, Occupational Health Service, St
Thomas’ Hospital, Westminster Bridge Rd, London SE1 7EH, UK
Full list of author information is available at the end of the article
© 2016 Madan et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Madan et al. Trials  (2016) 17:145 
DOI 10.1186/s13063-016-1255-y
(Continued from previous page)
outcome measures will be assessed.
Discussion: This trial will assess the clinical and cost effectiveness of an intervention to prevent hand dermatitis in nurses
in the United Kigdom.
Trial registration: ISRCTN53303171: date of registration, 21 June 2013.
Keywords: Dermatitis, Occupational health, Intervention, Nurses, Prevention, Randomised controlled trial, Behavioural
change, Moisturiser
Background
Occupational irritant hand dermatitis is a major risk in
healthcare. In a recent study, the 1-year prevalence of
self-reported hand dermatitis among healthcare workers
in a Dutch university medical hospital was 24 %, as com-
pared with less than 10 % in the general population [1].
Amongst healthcare workers, nurses are the group at
highest risk of hand dermatitis, with an estimated point
prevalence of 18–30 % [2, 3]. Moreover, in a study of
German geriatric nurses, two thirds of those who re-
ported hand dermatitis stated that it had developed after
they had joined the profession [2]. Consistent with this,
among Korean nursing students, the prevalence of hand
dermatitis increased from 7 % in the first year to 23 % in
the fourth year of training [4]. The costs of hand derma-
titis to the individual and employer are high. It not only
affects quality of life, but also can lead to loss of employ-
ment [5, 6]. Once an individual has developed irritant
hand dermatitis the prognosis is poor. In a 15-year follow-
up study of a Swedish general population sample, about a
third of those with hand dermatitis needed on-going med-
ical treatment and 5 % experienced long periods of sickness
absence, loss or change of job, or ill-health retirement [7].
Affected individuals may also experience negative psycho-
social consequences, such as sleep disturbance and interfer-
ence with leisure activities [7].
The high prevalence of hand dermatitis in nurses is
attributed to frequent hand-washing and poor hand-
drying techniques [8]. Current hand-cleansing policies in
the UK National Health Service (NHS) are driven by
efforts to reduce bacterial colonisation and transmission
of infections, and the emphasis is on frequent use of hand
rubs before and after patient contact, and washing with
soap and water if the hands are visibly soiled [8]. However,
little attention is paid to prevention of hand dermatitis.
For a nurse who develops irritant hand dermatitis, the
condition is likely to be aggravated by exposure to hand
hygiene measures. The presence of hand dermatitis may
discourage nurses from undertaking adequate hand de-
contamination due to discomfort or concern about ex-
acerbating skin lesions. It is known that 50 % of people
with hand dermatitis are colonised with Staphylococcus
aureus [9], and although controversial, there is a theoret-
ical risk that nurses with hand dermatitis infected by
methicillin-resistant Staphylococcus aureus (MRSA) could
transmit the infection to patients. Occupational health
(OH) professionals often have to advise nurses with active
dermatitis to refrain from work until the lesions are
healed, as it is difficult for them to avoid frequent hand-
washing unless they are redeployed to a non-clinical area.
Various measures might help to prevent hand derma-
titis in nurses and reduce the problems that it causes.
Moisturisers
Two systematic reviews of the management of occupa-
tional dermatitis [10, 11] have concluded that moisturisers
contributed importantly to both prevention and treatment
at work. A review by the former Occupational Health
Clinical Effectiveness Unit at the Royal College of Physi-
cians focussed on the evidence for managing established
occupational dermatitis, as distinct from prevention [10].
It found inconsistent evidence from two studies in which
moisturisers had been used as part of a complex interven-
tion in nurses [12, 13], but concluded that there was suffi-
cient evidence to recommend that skin care programmes
should include the use of emollients.
Guidelines produced by the British Occupational Health
Research Foundation [11] recommended that the regular
application of emollients helps to prevent the development
of occupational dermatitis, citing three high-quality studies
[14–16]. One randomised control trial (RCT) found an im-
provement in all outcomes, including clinical skin inspec-
tion. In the other, transepidermal water loss (TEWL)
improved among construction workers who used pre- and
after-work creams compared to controls, but there was no
difference in clinically assessed skin condition [15]. Moist-
urisers also improved skin condition in workers with dam-
aged skin [17]. More recent reviews have also concluded
that there is some evidence to support the use of educa-
tional interventions that include moisturisers, but this came
from a small number of workplace studies, and the authors
strongly recommended that further large high-quality RCTs
in working groups were needed [18, 19].
In the experience of the dermatologists and OH physi-
cians in our research team, moisturisers are not widely
used by healthcare workers in the UK. This anecdotal
observation is supported by a study of nurses working in
intensive care units (ICUs) in Germany which found that
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only 15 % of the 204 respondents reported that they ap-
plied moisturising creams after hand- washing and only
2 % after skin disinfection with hand rubs. Furthermore,
9 % never applied skin care to their hands and 72 % re-
ported that they did not perform final skin care after the
last hand-wash of the day [20].
Hand cleansing
The use of antibacterial hand rub with the addition of
moisturisers for hand hygiene reduces the drying and
cracking of the skin that commonly results from repeated
hand cleansing with soap and water [21]. In addition, anti-
bacterial hand rubs are associated with increased hand
hygiene compliance and reduced rates of nosocomial infec-
tion [22].
Hand-drying and glove use
Proper drying of the hands after washing is pivotal to
good hand hygiene and care, particularly as wet skin is
more likely to facilitate the transmission of bacteria than
dry skin. A recent review of hand-drying processes [23],
which included 12 studies, concluded that paper towels
are superior to electric air dryers and, therefore, should
be recommended in locations where hygiene is vital,
such as clinical environments. This was supported by
guidelines from the World Health Organization [8].
Skin care programmes that incorporate measures of the
type that have been described have shown a beneficial
effect in the prevention of hand dermatitis in healthcare
workers [12, 13, 24, 25]. However, a recent systematic
review suggested that educational programmes could
benefit from being more strongly informed by psycho-
logical theory, since their success relies on employees
adopting appropriate preventive and protective behaviours
[18]. Psychological theory has proved useful in understand-
ing the behavioural determinants of hand hygiene practices
among healthcare professionals [8, 26] and so is likely to
also be useful in the design of interventions to modify such
practices. Moreover, a meta-analysis of Internet-based be-
havioural change interventions found that more extensive
use of theory was associated with significantly greater ef-
fects and, in particular, that Internet interventions based on
the Theory of Planned Behaviour (TPB) tended to have
more substantial effects on behaviour [27]. One of the few
studies applying psychological theory to the prevention of
occupational hand dermatitis examined the TPB’s ability to
predict the behaviour of a sample of German patients with
occupational hand dermatitis receiving an inpatient tertiary
prevention programme. The TPB variables explained 30 %
of the variance in post-intervention dermatitis prevention
behaviour and 38 % of the variance in intentions for
preventive behaviours [28]. Systematic review of relevant
evidence shows that forming implementation intentions
and specific plans about how, when and where health-
promoting behaviours will be performed increases the
likelihood of individuals acting on their positive inten-
tions [29]. Furthermore, evidence suggests that remind-
ing individuals of their implementation intentions can
facilitate longer-term changes in behaviour [30, 31].
Although there are good reasons to expect that well-
designed skin care programmes would be beneficial for
nurses, their effectiveness and cost-effectiveness remain
uncertain. Trials to date have been limited by size and the
possibility that the control group was aware of the inter-
vention [32], or by a failure to address cost-effectiveness
[33]. There is a need for a pragmatic trial to evaluate the
clinical and cost-effectiveness of a behavioural change
programme (BCP) to improve the compliance of nurses
with measures to prevent occupational hand dermatitis.
Aims and objectives
1. We will test the hypothesis that a bespoke, web-based
behavioural change intervention to improve hand
care, coupled with provision of hand moisturisers, can
produce a clinically useful reduction in the prevalence
of objectively assessed hand dermatitis after 1 year,
when compared to standard care, among nurses
working in the National Health Service (NHS)
who are particularly at risk
2. Secondary aims will be to assess impacts on
participants’ beliefs and behaviour regarding hand
care (as a measure of adherence), days off sick over a
1-year follow-up period, and use of hand moisturisers
3. In addition, we will assess the cost-effectiveness of
the intervention compared with normal care
Method/Design
Concise statement of proposed research
We will conduct a cluster RCT of an intervention to
improve hand care at 35 sites (12 NHS acute hospital
trusts/health boards which provide OH care to both
student and ICU nurses, 18 NHS trusts which provide
OH care to ICU nurses and 5 university OH depart-
ments which provide OH care to student nurses). We
will focus on two groups of staff: (1) student nurses who
are about to start their first clinical placements, and who
are at increased risk of hand dermatitis because of a past
history of atopic disease or hand eczema; and (2) nurses
working in ICUs, who are at increased risk of hand
dermatitis because of the nature of their work.
Ethics approval to conduct the trial has been granted by
the National Research Ethics Service (NRES) Committee
London −City Road and Hampstead (REC reference: 13/
LO/0981). Ethical approval applies to all research sites
taking part in the study. Trial registration: ISRCTN num-
ber 53303171: date of registration, 21 June 2013.
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Design and theoretical/conceptual framework
The study will be a cluster RCT with sites as the unit of
randomisation. Sites will be randomly allocated to be
‘intervention-light’ or ‘intervention-plus’. Study group 1
will be student nurses who are about to start their first
clinical placements, and who are at increased risk of hand
dermatitis because of a past history of atopic disease or
hand eczema. Study group 2 will be nurses working in
ICUs who are at increased risk of hand dermatitis because
of the nature of their work. All participants are required
to provide written consent at the time of recruitment into
the study.
Intervention-plus
The intervention-plus in both staff groups will centre on
a bespoke online behavioural change package (BCP)
which will include advice: on when and when not to use
gloves; on when to use antibacterial hand rubs; on when
to use moisturising cream; and to contact OH early if
hand dermatitis occurs.
The BCP has been developed by members of the study
team with expertise in dermatology, occupational medi-
cine, nursing, and health psychology. Care has been taken
to ensure compatibility with current guidance on infection
control. We have emphasised WHO recommendations
that hands should only be washed with soap and water if
visibly soiled. At all other times, hands should be cleansed
with antibacterial hand rubs [8].
To maximise the probability of participants following
best practice, they will be asked to form implementation
intentions for performing each of the behaviours in their
workplace. A record of each participant’s implementa-
tion intentions will be generated by the online BCP
programme and emailed to them. In the event of a par-
ticipant being unable to access the online BCP, they will
be posted a paper-based magazine version of the BCP
which will reflect the information provided in the online
BCP. Participants will asked to read through the material
provided and write down their action plans in spaces
provided. They will then be asked to keep the paper-
based BCP in a convenient place so that they can refer
back to it as required.
The BCP will be supported by provision of facilities to
encourage adherence. These will include personal supplies
of moisturising cream for at-risk student nurses, and
provision of (1) optimal equipment for cleaning hands,
and (2) moisturising cream dispensers on ICUs.
The BCP will be made available to ICU nurses once they
have undergone baseline assessment (see below), and to
student nurses 2 weeks before they start their first clinical
attachment. It will be actively reinforced over the course of
the study by consistent messages on skin care from the
local OH and control of infection teams, and from local line
management. Research has shown that senior role models
have important effects on more junior healthcare workers’
hand hygiene behaviours [34, 35], and it seems reasonable
to assume that this influence will extend to behaviours that
prevent dermatitis. To facilitate this, when implementing
intervention-plus, we will engage in a dialogue with local
OH staff and line managers about the nature and purpose
of the study and will provide them with information on the
advice which will be given in the BCP, to ensure that they
promote consistent messages on skin care. The SCIN re-
search team will also write to any NHS sites at which
student nurses undertake clinical placements, but which
are not themselves participating study sites, to ensure they
are informed about the study.
We will offer the BCP online to allow nurses to access
it at a time convenient to their schedules, to permit
standardisation of the delivery of key information across
all intervention- plus sites, and to reduce the potential
burden on OH staff. Moreover, if the BCP is found to be
effective in this trial, it will be simple to scale up access
to the website in order to deliver the BCP across the
country.
Comparator (intervention-light)
Nurses at intervention-light sites will be managed accord-
ing to what would currently be regarded as best practice,
with provision of an advice leaflet about optimal hand care
entitled ‘Dermatitis: occupational aspects of management.
Evidence-based guidance for employees’ (also provided to
the intervention-plus group) and encouragement to
contact their OH department early if hand dermatitis
occurs. However, they will not receive the BCP or active
reinforcement of its messages. Nor will they routinely be
offered supplies of moisturising cream over and above
what is already standard practice at their site.
Sampling
We identified all NHS sites in the UK that train nurses,
have an in-house OH service, and have at least one ICU.
We first wrote to the lead occupational physician in each
eligible site in December 2011, asking their willingness,
in principle, to collaborate in a trial; and we wrote again
in May 2012 and January 2014 asking them to confirm
their willingness to collaborate. We also invited add-
itional sites to sign up to the study via national OH
newsletters. This included some sites that had an ICU
but did not train nurses, and vice versa. In order to
avoid the risk of student nurses moving placements from
an intervention to a control site (or vice versa) during
the study period, we generally invited only one site in
each city or town to participate in the study. The excep-
tions were London and Manchester. In London, three
sites were identified in which student nurses did not
move to neighbouring sites during their training. In
Manchester, we identified sites where students at three
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local universities undertake their clinical placements
during their first year of nursing training, and ensured
that these sites were clustered appropriately to prevent
cross-contamination in the study.
A summary of the number of participating sites is pro-
vided below:
 12 sites recruiting both ICU nurses and student
nurses (NHS trusts/health boards)
 18 sites recruiting ICU nurses only
(NHS trusts/health boards)
 5 sites recruiting student nurses only
(university-based OH departments)
Study group 1 – student nurses
All student nurses are required to attend for OH assess-
ment before starting their clinical work. At participating
sites, with permission from the universities concerned,
all student nurses in one or more year groups (excluding
mental health nursing students) who are due to start
their first clinical placement, will be sent a Participant
Information Sheet by their university or their OH de-
partment before or at the time of their mandatory as-
sessment. Those who have a history of atopic disease or
hand eczema will be identified by the OH department at
the assessment, from information that they provide in a
generic pre-placement health screening questionnaire. An
OH clinician will explain to them that because of their
constitution, they are at increased risk of hand dermatitis
and, therefore, need to take special care of their hands.
Those student nurses who meet the inclusion criteria will
then be invited to participate in the study. A field worker
will obtain written consent from those nurses who agree
(the lead OH practitioner at the study site and the trial
manager being available if needed to answer any ques-
tions). The consent form will ask participants to provide a
preferred email address and telephone number to facilitate
follow-up, and so that those at intervention-plus sites can
be sent a link to the online BCP. One copy of the signed
consent form will be filed in the nurse’s OH notes, one
copy will be sent to the trial manager, and a third copy will
be given to the participant. Participants will also be pro-
vided with an information sheet to give to their general
practitioner.
Study group 2 – intensive care nurses
The investigators, trial manager and lead OH clinicians
from each site will identify all ICUs (and a few also iden-
tified their special care baby units) that would be suit-
able for the study. A local OH clinician or senior ICU
nurse will explain to all nurses working on the selected
ICUs that they are at increased risk of hand dermatitis
because of frequent hand-washing with cleansers and
water. They will also be told that a study is being carried
out to help optimise management of nurses who are
higher risk. Full-time ICU nurses in the ICU (those
working at least 30 hours per week) will be provided
with a Participant Information Sheet and will be given
up to a week to decide whether they wish to participate
in the study. Consent to take part will be obtained by
the field worker, who along with the trial manager, will
be available to answer any queries about the study. The
consent form will ask participants to provide a preferred
email address to facilitate follow-up, and so that those at
intervention-plus sites can be sent a link to the online
BCP. Participants will be provided with an information
sheet to give to their general practitioner.
The study will be presented to both study groups as
research to assess the causes, consequences and ways of
preventing hand dermatitis in nurses who are at increased
risk, either because of a personal history of atopy or ec-
zema, or because of the type of work that they do. However,
to minimise the chance of bias, they will not be told that
they are in an intervention-plus or intervention-light group.
During the recruitment phase, field workers will reinforce
the importance that participants be able to commit fully to
the study, particularly with respect to the completion of
questionnaires (see below).
To check that rates of participation do not differ import-
antly between sites randomised to the two arms of the
study, the recruitment process will be carefully docu-
mented. The total numbers of eligible student and ICU
nurses will be recorded, as will the numbers who consent
to take part. We will also record the numbers who drop
out of the study, with the dates of drop out.
Data handling
Data from the trial will be handled by InferMed MACRO
v4 and data entry and handling will be audited.
Randomisation
Randomisation will be carried out using fixed blocks of
two, stratified by small or large site with or without student
nurses. Two sites will be randomised at a time and the
King’s Clinical Trials Unit will control the order of the ran-
domisation in order to ensure allocation concealment.
Baseline will be collected prior to randomisation.
For the purpose of analyses by intention-to-treat, the
date of entry into the study for each participant will be
date when they sign the consent form. Although student
nurses can only contribute useful information if they
progress to clinical work, in practice very few fail to do
so once they have begun their nursing studies.
Members of the study team will be notified of the out-
come of randomisation in a blinded or unblinded manner,
according to their role in the trial. The trial statistician
(GN), methodologist (DC), and the dermatologists (HW,
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JE) will remain blinded to treatment allocation until after
the primary analysis.
Sample size
Field workers will be encouraged to recruit as many
eligible student nurses and ICU nurses as possible, with
the aim of recruiting at least 40 student nurses and 40
nurses from the ICUs at each site.
To give an indication of power, we assumed that at the
end of follow-up the expected prevalence rates overall at
the intervention-light sites would be 24 % in both student
and ICU nurses, that the intraclass correlation coefficient
(ICC) is 0.05 (this corresponds to a variance inflation
factor of 2.05 for student nurses and 2.8 for ICU nurses),
and that 20 % of participants will be lost to follow-up.
With a 5 % level of statistical significance (two-sided), we
would have approximately 83 % power to detect a reduc-
tion in prevalence of dermatitis at follow-up in the
intervention-plus sites to 10 % in student nurses and 91 %
power to detect a reduction in prevalence to 10 % at
follow-up in ICU nurses. For final prevalence rates of
12 %, the powers would be 68 % for student nurses and
78 % for ICU nurses, while for final prevalence rates of
14 %, the corresponding powers would be 51 % and 61 %
respectively. The power will be higher if the ICC is lower
than 0.05. (These calculations were carried out using the
clustersampsi command in Stata v12.1 for difference in
proportions.)
Setting
OH departments (NHS and university-based) in the United
Kingdom (excluding a pilot site in Wales).
Data collection
Study group 1 – student nurses
Student nurses who agree to take part will be asked to
complete a self-administered baseline questionnaire (Ques-
tionnaire A) covering: contact details (which for security
reasons will be kept separate from the rest of the question-
naire); demographic information; history of atopic disease
and allergies; activities outside work which predispose to
hand dermatitis; beliefs and plans regarding dermatitis
prevention behaviours; the EuroQol-5D (EQ-5D) health-
related quality of life questionnaire [36] and history of hand
dermatitis ever, in the past 12 months, and currently. They
will be asked to place the completed questionnaire into a
sealed business reply envelope and return it to the SCIN
research team in London via the field worker, or if they
prefer, directly. In addition, they will be invited to have their
hands and wrists photographed.
Participants will be told that they may be asked to
access an online BCP, which they should undertake in
the week before starting their first clinical attachment,
and to which they will be sent a link (by email) 2 weeks
before the attachment begins. At that time, they will
also be sent (by post) a personal tube of moisturising
cream with guidance on how to request further supplies
if needed. All participants, at both intervention-plus
and intervention-light sites, will be encouraged (orally,
through a written advice leaflet, and by email reminders
at 4 and 8 months) to attend their OH department at
an early stage should they develop hand dermatitis.
One week after starting their first clinical attachment, all
participants will be asked to complete a further short self-
administered questionnaire (Questionnaire B), covering be-
liefs and plans regarding dermatitis prevention behaviours.
At intervention-plus sites, it will also ask about use of, and
views on, the BCP. Questionnaire B will be sent by post to
participants with a business reply envelope for return to the
SCIN research team.
To account for possible seasonal variation in the preva-
lence of dermatitis, final data collection will be carried out
12 months after baseline. All participants will be asked to
answer a third self-administered questionnaire (Question-
naire C) and again to have their hands photographed.
Questionnaire C will be distributed by the local field
workers, and will cover: clinical attachments undertaken in
the past year; hours worked per week over the past year;
beliefs and plans regarding dermatitis prevention behav-
iours; participation in, and views about, the BCP (only at
intervention-plus sites); activities outside work which pre-
dispose to hand dermatitis; recent practices regarding use
of gloves; recent practices regarding hand cleansing; recent
use of moisturising creams; history of hand dermatitis in
the past 12 months (including its investigation and treat-
ment, and any consequent loss of time from work or
restriction of duties); and the EQ-5D questionnaire. Student
nurses will be asked to place the completed Questionnaire
C into a sealed business reply envelope for return to the
SCIN team via the field worker or directly.
In addition, any attendance at OH with symptoms of
hand/wrist dermatitis and any requests for extra provision
of emollients during the study period will be documented.
Study group 2 – intensive care nurses
ICU nurses who agree to participate will be asked to
complete a self-administered baseline questionnaire (Ques-
tionnaire A) similar to that for student nurses, but also
including items on current occupation; recent practices
regarding use of gloves; recent practices regarding hand
cleansing; recent use of moisturising creams; and any sick-
ness absence or modification of duties during the past
12 months because of hand dermatitis. Arrangements for
the return of completed questionnaires will be as for
student nurses. They will also have their hands and wrists
photographed.
Once recruitment has been completed, field workers
at intervention-plus sites will promote the importance of
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optimising equipment for hand cleansing, and dispensa-
tion of moisturising cream. The written leaflet about
prevention of hand dermatitis will be made available to
all staff on the ward (not only those individuals who
have consented to take part in the study), and an email
will be sent via the lead ICU nurses to all staff on the
ward with a link to the BCP. Uptake of the BCP will be
documented.
Following recruitment, all ICU nurses (not just
those who have agreed to participate in the study) at
intervention-light sites will also be given the written
leaflet about prevention of hand dermatitis.
Two weeks after the BCP has been offered (or at a simi-
lar interval after recruitment in the intervention-light
sites), participants will be asked to complete a second
questionnaire (Questionnaire B) about beliefs regarding
prevention of dermatitis and (at intervention-plus sites)
participation in, and views on the BCP. Questionnaire B
will be sent to participants by post with a business reply
envelope. All participants at both the intervention-plus
and intervention-light sites will be encouraged (orally,
through the written advice leaflet and by email re-
minders sent out by the SCIN research team at 4 and
8 months) to attend the OH department at an early
stage should they develop hand dermatitis. Email re-
minders will also contain a positive reinforcement mes-
sage to encourage ongoing participation in the study. In
addition, at the intervention sites, the email reminders
will reinforce the BCP.
Outcomes will be assessed 12 months after baseline.
All participants will be asked to complete a final self-
administered questionnaire (Questionnaire C), and again
to have their hands and wrists photographed. Question-
naire C will be sent out to field workers by the SCIN
research team 2 months before the end of the study, and
they in turn will pass them on to participants at the time
that they recall them to have their hands photographed.
The nurses will be asked to place the completed ques-
tionnaire into a sealed business reply envelope and
return it via field worker or directly to the SCIN team in
London.
Withdrawal from the study
Participants who decide to withdraw from the study, for
whatever reason, will be asked to complete a shortened
version of Questionnaire C and will be invited to have
follow-up photographs of their hands and wrists.
Study instruments and data collection tools
Questionnaires
The study questionnaires have been developed specifically
for this study, and piloted in a sample of 22 student nurses
and 22 ICU nurses. Questions about dermatitis are derived
from the Nordic Occupational Skin Questionnaire [37].
The EQ-5D health-related quality of life questionnaire [36]
has been included and the questions on beliefs are based
on the structure suggested for assessing TPB [38] and are
informed by information we obtained from focus groups
on student and ICU nurses.
Throughout the study, non-responders to any of the
three study questionnaires will be sent an email reminder
from the SCIN research team with a request that they
complete and return the questionnaire directly to the
SCIN team. If questionnaires remain outstanding, another
copy of the paper questionnaire will be posted to the
participant’s preferred postal address, along with a busi-
ness reply envelope. If questionnaires remain outstanding
after a further 2 weeks, participants will be sent up to two
reminder text messages (or telephone messages if they
have given a land line number).
At the end of the study period, participants who have
completed and returned all three study questionnaires
will be entered into a prize draw, giving them a chance
to win one of the study cameras (a total of 26 cameras
will be offered). Information about the draw and prizes
will be included in the Participant Information Sheet.
Ascertainment of hand dermatitis and description of the
photographic method
The protocol for photographing hands and wrists has
been developed in consultation with a medical photog-
rapher and is consistent with the views required for the
photographic assessment scale described by Coenraads
[39]. It prescribes a method for obtaining repeatable
standardised digital images that allow assessment of skin
condition and colour.
As a last resort, where the local field worker is unable to
make personal contact with a participant at follow-up,
they will be offered an opportunity to send the SCIN
research team ‘selfie’ photographs of their hands and
wrists.
Initial assessment of photographs will be carried out
by a dermatology research nurse (blind to intervention
group), who will classify them as showing ‘definite/pos-
sible dermatitis’ or ‘no dermatitis’. All images classed as
‘definite/possible dermatitis’, together with a sample of
250 that are classed as ‘no dermatitis’ will then be
assessed independently by two dermatologists. Final de-
termination of whether or not dermatitis is present will
be according to the opinion of the dermatologists, with
any differences between them resolved by discussion.
Provided the dermatologists do not identify a significant
rate of dermatitis among the images that the nurse ori-
ginally classed as ‘no dermatitis’, her assessment of ‘no
dermatitis’ will be accepted for the images that were not
selected for dermatologist assessment.
Our rationale for ascertaining any, and not only more se-
vere hand dermatitis, is that even minimal hand dermatitis
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progresses to significant hand eczema in a cumulative way
over time [39]. However, the dermatologists will also grade
disease severity since severe hand dermatitis causes more
distress and is associated with greater loss of time from
work. We will use a method developed by Coenraads et
al. [39] for classifying hand eczema severity: a simple
categorization into five grades (clear, almost clear, mild,
moderate, severe and very severe). Again, differences
between the two dermatologists will be resolved by
discussion.
Data analysis
Outcomes will be assessed separately for the two study
groups (student nurses and ICU nurses).
Outcome measures For each study group, the princi-
pal outcome measure will be the difference between
intervention-plus and intervention-light sites in the
change in point prevalence of visible hand dermatitis
from baseline to the end of follow-up.
Secondary outcomes will be the difference between
intervention and control sites in:
 The difference between intervention and control
sites in the change in prevalence and severity of
visible hand dermatitis from baseline to the end of
follow-up (as ascertained by the dermatologists)
 Days lost from sickness absence and days of
modified duties because of hand dermatitis per
100 days of nurse time during the 12 months of
follow-up
 The change from baseline to after completion of the
BCP, and to the end of the 12-month follow-up in
beliefs about dermatitis prevention behaviours
 The change from baseline to the end of follow-up in
the reported frequency of: use of hand rubs for hand
cleansing; hand-washing with water; and use of
moisturising creams (for student nurses, who will
not have started clinical attachments at the
beginning of the study, this will reduce to differences
between the intervention and control sites at the
end of the follow-up)
 The change from baseline to the end of follow-up in
quality of life score
 The use of moisturiser provided for the intervention
(in terms of requests for further supplies by student
nurses and orders for supplies of moisturisers by
ICUs)
We will also document the reported participation in the
BCP, reasons given for not participating, and comments
on its content.
Method of analysis
Differences in changes in the prevalence of the primary and
secondary outcomes from baseline to follow-up between
the two arms will be assessed by random-intercept multi-
level models to account for possible clustering by site. For
the primary outcome, the relative odds of having dermatitis
at follow-up in the intervention-plus group as compared to
the intervention-light group after adjusting for dermatitis at
baseline will be estimated using a random-intercept logistic
regression model. If inadvertent potentially confounding
changes occur at some sites during the course of the study,
we will carry out sensitivity analyses excluding the sites
concerned. We will test whether differences between the
intervention and control groups in dermatitis prevention
behaviours are mediated by differences in beliefs and plans
about the relevant behaviour.
Economic analysis
In addition to analyses of clinical effectiveness, we will
assess the cost-effectiveness of the interventions in the
two staff groups from a healthcare and societal perspec-
tive. Healthcare costs will be calculated for the 12-month
follow-up period and will be based on the number of
contacts with clinical staff (occupational health, primary
care staff, dermatologists, etc.) as a result of hand derma-
titis, combined with appropriate unit cost information
[40] and the cost of supplying moisturising creams (with
costs obtained from the British National Formulary (BNF)
for prescribed formulations). The service use information
will be collected using a short self-report schedule based
on the Client Service Receipt Inventory. These service
costs will be added to the cost of the BCP itself, which will
be based on development time and staff time accessing
the package. Societal costs will be calculated by adding
healthcare costs to the costs of lost production, based on
days off work combined with wage rates. Cost compari-
sons between the groups will be made using bootstrapped
regression models assuming that the cost data are skewed.
Costs from both perspectives will be combined with the
primary outcome measure in a cost-effectiveness analysis.
If costs are reduced for one group and outcomes are bet-
ter then it will be ‘dominant’. If one group has higher costs
and better outcomes then incremental cost-effectiveness
ratios (ICERs) will be generated, defined as the difference
in costs divided by the difference in outcomes. Using the
primary outcome measure, the ICER will indicate the
extra cost incurred for one extra participant to be free
of visible hand dermatitis in either hand at 12-month
follow-up. There will be uncertainty around the cost
and effectiveness estimates and this will be addressed
using cost-effectiveness planes generated through re-
peated resampling from the data set to generate 1000
cost-outcome combinations and plotting these. To in-
form healthcare spending decisions it is helpful also to
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combine costs with quality-adjusted life years (QALYs).
The most widely used QALY measure in England is the
EQ-5D, which has been recommended for dermatological
interventions [36]. This measure will be used at baseline
and follow-up, and area under the curve methods used to
produce QALYs. Similar analyses to those described above
will be conducted to assess the relationship between costs
and QALYs, but we will also generate cost-effectiveness
acceptability curves (CEACs) to show the probability that
the intervention is cost-effective for different threshold
values placed on a QALY [41]. CEACs will still be produced
but will be more exploratory; they will be used to identify
threshold values where the likelihood of the intervention
being cost-effective is 50 %, 60 %, 70 %, 80 % and 90 %).
While standard unit costs are being used for most services
it will be necessary to calculate the intervention costs spe-
cifically for the study. This will be based on estimates of
staff time spent developing the intervention and staff time
spent accessing it. We will increase/decrease both of these
aspects in sensitivity analyses by 10–50 % to see the impact
that these changes have on the probability that the inter-
vention is cost-effective at the £20,000 and £30,000 QALY
thresholds. Sensitivity analyses will also be conducted on
the societal cost-effectiveness estimates by increasing/de-
creasing the cost of lost work time by 10–50 % and asses-
sing the impact on the CEACs.
If the intervention is shown to be cost-effective then we
will make estimates of the number of nurses who might
access the intervention were it to become recommended
practice. This will in turn allow us to estimate the budget
impact for the NHS and the benefits in terms of total
QALYs gained. Uncertainty around these estimates will
be investigated through the sensitivity analyses describe
above.
Process evaluation
We will collect data on and describe:
1. Uptake of the intervention, in terms of:
 Proportion of eligible nurses who access the
online BCP
 Proportion of eligible nurses who complete the
online BCP
2. Acceptability of the intervention in terms of:
 Perceived interest, relevance to role and
likelihood of recommending it to colleagues
Discussion
A range of operational and practical issues have arisen dur-
ing the planning and implementation of the trial, including:
1. A large number of sites whose personnel had
initially expressed an interest in taking part in the
study were later unable to proceed due to various
local issues (e.g. a subsequent reduction in OH staff
to support the study or an increase in routine
operational workload). As a consequence, it was
necessary to invite additional OH services to take
part in the study. This has enabled the research
team to increase the total number of sites taking
part in the study from the number initially planned
2. The recruitment rate in some sites has been lower
than expected; therefore, to improve the number of
participants taking part in the study, the research
team have requested participating sites (where
possible) to undertake a second round of
recruitment. In addition, the research team agree to
broaden the inclusion criteria for ‘critical care
nurses’ to also include ‘special care baby unit’ nurses:
3. A dedicated full-time research nurse has been
recruited to the central research. Their role will be
to assist with further recruitment and capturing
follow-up data at participating sites
Trial status
At the time of submission, the main trial has been under-
way since September 2014, with final recruitment planned
for March 2016. The trial will be completed no later than
September 2017 (pending approval from the funder).
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